Vishay Reports Results for Second Quarter 2017
Aug 03, 2017 11:30 am UTC| Business
Revenues for Q2 2017 of $645 millionGross Margin Q2 of 26.8%Adjusted Operating Margin Q2 of 12.8%EPS Q2 of $0.36Adjusted EPS Q2 of $0.36Cash from operations for trailing twelve months Q2 of $329 million and capital...
Bel Reports Second Quarter 2017 Results
Aug 03, 2017 11:30 am UTC| Business
JERSEY CITY, N.J., Aug. 03, 2017 -- Bel Fuse Inc. (NASDAQ:BELFA) (NASDAQ:BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, announces preliminary financial results for...
KemPharm to Present at Canaccord Genuity 37th Annual Growth Conference
Aug 03, 2017 11:30 am UTC| Business
CORALVILLE, Iowa, Aug. 03, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that its president and...
Aug 03, 2017 11:30 am UTC| Business
IRVINE, Calif., Aug. 03, 2017 -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID), announces today that the law firm Lounsbery, Ferguson, Altona Peak LLP (LFAP)...
MGP Ingredients Reports Second Quarter 2017 Results
Aug 03, 2017 11:30 am UTC| Business
ATCHISON, Kan., Aug. 03, 2017 -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today reported results for the second quarter ended June...
ReWalk Robotics Reports Second Quarter 2017 Financial Results
Aug 03, 2017 11:30 am UTC| Business
-- 146% YOY growth in Q2 revenue to $2 million and record 1H revenue of $4.5 million – -- 11 favorable commercial case-by-case insurance coverage decisions -- -- 217 pending insurance claims in the U.S. and Germany -- --...
Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update
Aug 03, 2017 11:30 am UTC| Business
On Track to Report Top-Line Results from Phase 3 CONVERT Study in September plus or minus one month Plan to Initiate Enrollment of Phase 2 Dose-ranging Study of INS1007 in Non-Cystic Fibrosis (non-CF) Bronchiectasis in...